PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.56%
Revenue growth under 50% of MU's 10.99%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-0.22%
Negative gross profit growth while MU is at 9.77%. Joel Greenblatt would examine cost competitiveness or demand decline.
-0.70%
Negative EBIT growth while MU is at 17.75%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1.65%
Negative operating income growth while MU is at 17.75%. Joel Greenblatt would press for urgent turnaround measures.
0.17%
Net income growth under 50% of MU's 16.04%. Michael Burry would suspect the firm is falling well behind a key competitor.
1.21%
EPS growth under 50% of MU's 18.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
0.82%
Diluted EPS growth under 50% of MU's 17.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.76%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.75%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.09%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
56.45%
OCF growth above 1.5x MU's 5.79%. David Dodd would confirm a clear edge in underlying cash generation.
68.74%
FCF growth above 1.5x MU's 23.89%. David Dodd would verify if the firm’s strategic investments yield superior returns.
91.35%
10Y revenue/share CAGR under 50% of MU's 253.26%. Michael Burry would suspect a lasting competitive disadvantage.
37.79%
5Y revenue/share CAGR at 50-75% of MU's 54.43%. Martin Whitman would worry about a lagging mid-term growth trajectory.
42.33%
3Y revenue/share CAGR at 50-75% of MU's 79.36%. Martin Whitman would question if the firm lags behind competitor innovations.
184.81%
10Y OCF/share CAGR under 50% of MU's 396.74%. Michael Burry would worry about a persistent underperformance in cash creation.
73.82%
5Y OCF/share CAGR 1.25-1.5x MU's 58.59%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
42.20%
3Y OCF/share CAGR similar to MU's 40.68%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
262.30%
Below 50% of MU's 828.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
93.27%
5Y net income/share CAGR above 1.5x MU's 58.58%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
64.93%
Below 50% of MU's 210.65%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
57.46%
Below 50% of MU's 460.17%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.87%
Below 50% of MU's 203.10%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
65.35%
3Y equity/share CAGR above 1.5x MU's 38.64%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
570.52%
Dividend/share CAGR of 570.52% while MU is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
129.76%
Dividend/share CAGR of 129.76% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
49.28%
3Y dividend/share CAGR of 49.28% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-6.85%
Firm’s AR is declining while MU shows 15.69%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
9.32%
Inventory growth well above MU's 4.57%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.40%
Asset growth above 1.5x MU's 2.51%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
3.73%
50-75% of MU's 5.04%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
9.57%
Debt growth far above MU's 0.51%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
4.11%
We increase R&D while MU cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
2.13%
SG&A growth well above MU's 0.38%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.